Literature DB >> 27173678

The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study.

Julita Kulbacka1, Agata Pucek2, Kazimiera Anna Wilk2, Magda Dubińska-Magiera3, Joanna Rossowska4, Marek Kulbacki5, Małgorzata Kotulska6.   

Abstract

Drug delivery technology is still a dynamically developing field of medicine. The main direction in nanotechnology research (nanocarriers, nanovehicles, etc.) is efficient drug delivery to target cells with simultaneous drug reduction concentration. However, nanotechnology trends in reducing the carrier sizes to several nanometers limit the volume of the loaded substance and may pose a danger of uncontrolled access into the cells. On the other hand, nanoparticles larger than 200 nm in diameter have difficulties to undergo rapid diffusional transport through cell membranes. The main advantage of large nanoparticles is higher drug encapsulation efficiency and the ability to deliver a wider array of drugs. Our present study contributes a new approach with large Tween 80 solid lipid nanoparticles SLN (i.e., hydrodynamic GM-SLN-glycerol monostearate, GM, as the lipid and ATO5-SLNs-glyceryl palmitostearate, ATO5, as the lipid) with diameters DH of 379.4 nm and 547 nm, respectively. They are used as drug carriers alone and in combination with electroporation (EP) induced by millisecond pulsed electric fields. We evaluate if EP can support the transport of large nanocarriers into cells. The study was performed with two cell lines: human colon adenocarcinoma LoVo and hamster ovarian fibroblastoid CHO-K1 with coumarin 6 (C6) as a fluorescent marker for encapsulation. The biological safety of the potential treatment procedure was evaluated with cell viability after their exposure to nanoparticles and EP. The EP efficacy was evaluated by FACS method. The impact on intracellular structure organization of cytoskeleton was visualized by CLSM method with alpha-actin and beta-tubulin. The obtained results indicate low cytotoxicity of both carrier types, free and loaded with C6. The evaluation of cytoskeleton proteins indicated no intracellular structure damage. The intracellular uptake and accumulation show that SLNs do not support transport of C6 coumarin. Only application of electroporation improved the transport of encapsulated and free C6 into both treated cell lines.

Entities:  

Keywords:  Coumarin-6; Drug delivery; Electroporation; Millisecond pulsed electric field; Solid lipid nanocarriers

Mesh:

Substances:

Year:  2016        PMID: 27173678      PMCID: PMC5045845          DOI: 10.1007/s00232-016-9906-1

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  72 in total

1.  In vivo gene delivery by electroporation.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-01-04       Impact factor: 15.470

Review 2.  Solid lipid nanoparticles: production, characterization and applications.

Authors:  W Mehnert; K Mäder
Journal:  Adv Drug Deliv Rev       Date:  2001-04-25       Impact factor: 15.470

3.  The use of Chinese hamster ovary (CHO) cells in the study of ion channels.

Authors:  Nikita Gamper; James D Stockand; Mark S Shapiro
Journal:  J Pharmacol Toxicol Methods       Date:  2005-03-23       Impact factor: 1.950

4.  Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin.

Authors:  M Cemazar; G Sersa; D Miklavcic
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

5.  Doxorubicin delivery enhanced by electroporation to gastrointestinal adenocarcinoma cells with P-gp overexpression.

Authors:  Julita Kulbacka; Małgorzata Daczewska; Magda Dubińska-Magiera; Anna Choromańska; Nina Rembiałkowska; Paweł Surowiak; Marek Kulbacki; Małgorzata Kotulska; Jolanta Saczko
Journal:  Bioelectrochemistry       Date:  2014-04-04       Impact factor: 5.373

6.  In vivo electrically mediated protein and gene transfer in murine melanoma.

Authors:  M P Rols; C Delteil; M Golzio; P Dumond; S Cros; J Teissie
Journal:  Nat Biotechnol       Date:  1998-02       Impact factor: 54.908

Review 7.  Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy.

Authors:  Ruggero Cadossi; Mattia Ronchetti; Matteo Cadossi
Journal:  Future Oncol       Date:  2014-04       Impact factor: 3.404

8.  Gene electrotransfer in clinical trials.

Authors:  Julie Gehl
Journal:  Methods Mol Biol       Date:  2014

9.  Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer.

Authors:  Julie Orio; Elisabeth Bellard; Houda Baaziz; Chantal Pichon; Peter Mouritzen; Marie-Pierre Rols; Justin Teissié; Muriel Golzio; Sophie Chabot
Journal:  J RNAi Gene Silencing       Date:  2013-03-15

10.  Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.

Authors:  P F Forde; M Sadadcharam; L J Hall; T R O' Donovan; M de Kruijf; W L Byrne; G C O' Sullivan; D M Soden
Journal:  Cancer Gene Ther       Date:  2014-07-18       Impact factor: 5.987

View more
  3 in total

1.  Nanoemulsion Structural Design in Co-Encapsulation of Hybrid Multifunctional Agents: Influence of the Smart PLGA Polymers on the Nanosystem-Enhanced Delivery and Electro-Photodynamic Treatment.

Authors:  Urszula Bazylińska; Julita Kulbacka; Grzegorz Chodaczek
Journal:  Pharmaceutics       Date:  2019-08-11       Impact factor: 6.321

2.  Curcumin Loaded Nanocarriers with Varying Charges Augmented with Electroporation Designed for Colon Cancer Therapy.

Authors:  Julita Kulbacka; Kazimiera A Wilk; Urszula Bazylińska; Magda Dubińska-Magiera; Stanisław Potoczek; Jolanta Saczko
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

Review 3.  Benefitial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspective.

Authors:  Oliwia Kozak; Stanisław Hać; Joanna Pieńkowska; Michał Studniarek
Journal:  Pol J Radiol       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.